Stocks›Healthcare

CHOKSI ASIA LIMITED

CHOKSI · BSE · Healthcare · As of 8 Nov 2026

₹216.00

+₹5.65 (+2.69%)(1D)

₹100.1052 Week Range₹266.45

Market Cap

₹83.41 Cr

P/E (Sector)

23.1 (32.3)

P/B Ratio

—

Dividend Yield

—

ROE

9.4%

Debt / Equity

—

Anvest Score

32/100

Valuation

0/100

Quality

27/100

Growth

37/100

Health

—

Omitted

Momentum

81/100

Valuation
0
Quality
27
Growth
37
Health
—
Momentum
81

AI Company ProfileFiling-backed

AI Snapshot

CHOKSI ASIA LIMITED operates in Medical Equipment & Supplies within the Healthcare sector. Its business model would involve sourcing products, managing supply chains, and sales to its customer base within India.

Medical Equipment & SuppliesFounded:1992CEO/MD:Samir ChoksiHQ:Mumbai, Maharashtra, India

Business profile as of period ended 25 Aug 2026

Revenue growth: +33.3%FY26 growth
PAT growth: +72.5%FY26 growth

What Looks Strong

MarketShareholder returns of +40.9% CAGR over five years.
TrendPrice momentum is strong, with the stock trading comfortably above its 200-day trend.

What to Watch

No material watchpoint identified from currently verified evidence.

Loading company profile…

Fundamentals

P/E Ratio (TTM)

23.08

Sector median P/E

32.29

P/B Ratio

—

Sector median P/B

4.4

EPS (TTM)

₹9.36

Market Cap

₹83.41 Cr

ROE

9.36%

ROCE

3.95%

Profit Margin

10.51%

CHOKSI ASIA LIMITED FAQs

3 topics

Expand

What does the CHOKSI ASIA LIMITED (CHOKSI) stock page cover?

CHOKSI ASIA LIMITED on Anvest includes delayed price context, valuation ratios, a one-year price range, and section-level research data when available.

What are the current headline metrics for CHOKSI?

CHOKSI ASIA LIMITED is currently shown with a delayed price near ₹216, P/E 23.08, and ROE 9.36%.

Does the CHOKSI page provide investment advice?

No. The CHOKSI page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.

Keep exploring